The Tumor Immune Microenvironment Is Associated With Recurrence in Early-Stage Lung Adenocarcinoma

CONCLUSIONS: PD-L1 expression on tumor cells, CD8+ T cell infiltration, and TP53 mutation status may help identify patients with early-stage NSCLC susceptible to recurrence after adjuvant chemotherapy.PMID:38651033 | PMC:PMC11033192 | DOI:10.1016/j.jtocrr.2024.100658

Source: Cell Research - April 23, 2024 Category: Cytology Authors: Hiroaki Kanemura Toshihide Yokoyama Ryu Nakajima Atsushi Nakamura Hiroaki Kuroda Yoshitaka Kitamura Hiroyasu Shoda Nobuaki Mamesaya Yoshihiro Miyata Tatsuro Okamoto Kyoichi Okishio Masahide Oki Yuichi Sakairi Toyofumi Fengshi Chen-Yoshikawa Tadashi Aoki T Source Type: research